Clinical trials
Sickle Cell Trait trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 8 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Not yet recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| Pfizer | 3 |
| Columbia University | 2 |
| Forma Therapeutics, Inc. | 2 |
| Hospices Civils de Lyon | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Novartis Pharmaceuticals | 2 |
| UConn Health | 2 |
| Albert Einstein College of Medicine | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sickle Cell Trait | 43 |
| Anemia, Sickle Cell | 28 |
| Vaso-Occlusive Crises | 7 |
| Hematologic Diseases | 6 |
| Anemia | 4 |
| beta-Thalassemia | 4 |
| Disease | 3 |
| Anemia, Hemolytic | 2 |
| Anxiety Disorders | 2 |
| Diabetes Mellitus | 2 |
Trials
Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.